Authors' Reply

Pagot R Cramer P L'Heritier C Coquelin JP Attali P . Comparison of the efficacy and tolerability of zolpidem 20 mg and triazolam 0.5 mg in anxious or depressed insomniac patients. Curr Ther Res 1993; 53: 88–97.

Ochs R Fullingam J Cutter N Leppik I Lucas E Cohn M . The effect of zolpidem in elderly patients with chronic insomnia (abstract). J Sleep Res 1992; 1 (suppl 1): 164.

Lund R Ruther E Wober W Hippius H . Effects of zolpidem (10 and 20 mg), lormetazepam, triazolam, and placebo on night sleep and residual effects during the day. In: Sauvanet JP Langer SZ Morselli PL , eds. Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach. New York: Raven Press, 1988: 193–203.

Rosenberg J Ahlstrom F . Randomized, double-blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice. Scand J Prim Health Care 1994; 12: 88–92.

Roger M Attali P Coquelin JP . Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther 1993; 15: 127–36.

Louvel E Cramer P Ferreri M Pagot R Regnier F L'Heritier C . Zolpidem and triazolam: long-term multicenter studies (1-3 months) in psychiatric and general practice patients. In: Sauvanet JP Langer SZ Morselli PL , eds. Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach. New York: Raven Press, 1988: 327–37.

Morgan PJ Chapados R Chung FF Gauthier M Knox JW LeLorier J . Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery. J Clin Anesth 1997; 9: 97–102.

Wesensten NJ Balkin TJ Belenky GL . Effects of daytime administration of zolpidem and triazolam on performance. Aviat Space Environ Med 1996; 67: 115–20.

Wesensten NJ Balkin TJ Belenky GL . Effects of daytime administration of zolpidem versus triazolam on memory. Eur J Clin Pharmacol 1995; 48: 115–22.

Balkin TJ Odonnell VM Wesensten N McCann U Belenky G . Comparison of the daytime sleep and performance effects of zolpidem versus triazolam. Psychopharmacology 1992; 107: 83–8.

Morselli PL Larribaud J Guillet P Thiercilin JF Barthelet G Grilliat JP . Daytime residual effects of zolpidem: a review of available data. In: Sauvanet JP Langer SZ Morselli PL , eds. Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach. New York: Raven Press, 1988: 183–91.

Greenblatt DJ Harmatz JS Shader RI . Does zolpidem have unique clinical properties? A pharmacodynamic comparison with triazolam and placebo (abstract). Clin Pharmacol Ther 1996, 59: 178.

Berlin I Warot D Hergueta T Molinier P Bagot C Puech AJ . Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 1993; 13: 100–6.

Roehrs T Merlotti L Zorick F Roth T . Sedative, memory, and performance effects of hypnotics. Psychopharmacology 1994; 116: 130–4.

Rush CR Griffiths RR . Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 1996; 16: 146–57.

Monti JM Attali P Monti D Zipfel A de la Giclais B Morselli PL . Zolpidem and rebound insomnia — a double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatry 1994; 27: 166–75.

Silvestri R Ferrillo F Murri L Massetani R DiPerri R Rosadini G . Rebound insomnia after abrupt discontinuation of hypnotic treatment: double-blind randomised comparison of zolpidem versus triazolam. Hum Psychopharmacol 1996; 11: 225–33.

Sanchez LG Sanchez JM Moreno JL Lopez . Dependence and tolerance with zolpidem (letter). Am J Health-Syst Pharm 1996; 53: 2638.

Gericke CA Ludolph AC . Chronic abuse of zolpidem. JAMA 1994; 272: 1721–2.

van Puijenbroek EP Egberts AC Krom HJ . Visual hallucinations and amnesia associated with the use of zolpidem (letter). Int J Clin Pharmacol Ther 1996; 34: 318.

Markowitz JS Brewerton TD . Zolpidem-induced psychosis. Ann Clin Psychiatry 1996; 8: 89–91.

Canaday BR . Amnesia possibly associated with zolpidem administration. Pharmacotherapy 1996; 16: 687–9.

Cavallaro R Regazzetti MG Covelli G . Tolerance and withdrawal with zolpidem. Lancet 1993; 342: 374–5.

Evans SM Funderburk FR Griffiths RR . Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 1990; 225: 1246–55.

Rush CR Madakasira S Goldman NH Woolverton WL Rowlett JK . Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther 1997; 280: 174–88.

Pichard L Gillet G Bonfils C Domergue J Thenot JP Maurel P . Oxidative metabolism of zolpidem by human liver cytochrome P450s. Drug Metab Dispos 1995; 23: 1253–62.

Product information Norvir (ritonavir capsules). North Chicago: Abbott Laboratories, 1996.

Product information Ambien (zolpidem tablets). Chicago: GD Searle and Company, 1995.